Precise Investigation of the Efficacy of Multicomponent Drugs Against Pneumonia Infected With Influenza Virus

Background: Viral pneumonia is one of the most serious respiratory diseases, and multicomponent traditional Chinese medicines have been applied in the management of infected patients. As a representative TCM, HouYanQing (HYQ) oral liquid shows antiviral activity. However, the unclear mechanisms, as...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Junying Wei, Jianhui Sun, Jiawei Zeng, Enhui Ji, Jing Xu, Chunyu Tang, Hairu Huo, Yi Zhang, Hongmei Li, Hongjun Yang
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/b6d85b1016c9443280deb3843640f9d8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b6d85b1016c9443280deb3843640f9d8
record_format dspace
spelling oai:doaj.org-article:b6d85b1016c9443280deb3843640f9d82021-11-18T05:08:08ZPrecise Investigation of the Efficacy of Multicomponent Drugs Against Pneumonia Infected With Influenza Virus1663-981210.3389/fphar.2021.604009https://doaj.org/article/b6d85b1016c9443280deb3843640f9d82021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fphar.2021.604009/fullhttps://doaj.org/toc/1663-9812Background: Viral pneumonia is one of the most serious respiratory diseases, and multicomponent traditional Chinese medicines have been applied in the management of infected patients. As a representative TCM, HouYanQing (HYQ) oral liquid shows antiviral activity. However, the unclear mechanisms, as well as the ambiguous clinical effects, limit widespread application of this treatment. Therefore, in this study, a proteomics-based approach was utilized to precisely investigate its efficacy.Methods: Based on the efficacy evaluation of HYQ in a mouse model of pneumonia caused by influenza A virus (H1N1) and the subsequent proteomics analysis, specific signatures regulated by HYQ treatment of viral pneumonia were identified.Results: Experimental verifications indicate that HYQ may show distinctive effects in viral pneumonia patients, such as elevated galectin-3-binding protein and glutathione peroxidase 3 levels.Conclusion: This study provides a precise investigation of the efficacy of a multicomponent drug against viral pneumonia and offers a promising alternative for personalized management of viral pneumonia.Junying WeiJianhui SunJiawei ZengEnhui JiJing XuChunyu TangHairu HuoYi ZhangHongmei LiHongjun YangFrontiers Media S.A.articlepneumoniaprecise medicinemulticomponent drugproteomicshouyanqing oral liquidTherapeutics. PharmacologyRM1-950ENFrontiers in Pharmacology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic pneumonia
precise medicine
multicomponent drug
proteomics
houyanqing oral liquid
Therapeutics. Pharmacology
RM1-950
spellingShingle pneumonia
precise medicine
multicomponent drug
proteomics
houyanqing oral liquid
Therapeutics. Pharmacology
RM1-950
Junying Wei
Jianhui Sun
Jiawei Zeng
Enhui Ji
Jing Xu
Chunyu Tang
Hairu Huo
Yi Zhang
Hongmei Li
Hongjun Yang
Precise Investigation of the Efficacy of Multicomponent Drugs Against Pneumonia Infected With Influenza Virus
description Background: Viral pneumonia is one of the most serious respiratory diseases, and multicomponent traditional Chinese medicines have been applied in the management of infected patients. As a representative TCM, HouYanQing (HYQ) oral liquid shows antiviral activity. However, the unclear mechanisms, as well as the ambiguous clinical effects, limit widespread application of this treatment. Therefore, in this study, a proteomics-based approach was utilized to precisely investigate its efficacy.Methods: Based on the efficacy evaluation of HYQ in a mouse model of pneumonia caused by influenza A virus (H1N1) and the subsequent proteomics analysis, specific signatures regulated by HYQ treatment of viral pneumonia were identified.Results: Experimental verifications indicate that HYQ may show distinctive effects in viral pneumonia patients, such as elevated galectin-3-binding protein and glutathione peroxidase 3 levels.Conclusion: This study provides a precise investigation of the efficacy of a multicomponent drug against viral pneumonia and offers a promising alternative for personalized management of viral pneumonia.
format article
author Junying Wei
Jianhui Sun
Jiawei Zeng
Enhui Ji
Jing Xu
Chunyu Tang
Hairu Huo
Yi Zhang
Hongmei Li
Hongjun Yang
author_facet Junying Wei
Jianhui Sun
Jiawei Zeng
Enhui Ji
Jing Xu
Chunyu Tang
Hairu Huo
Yi Zhang
Hongmei Li
Hongjun Yang
author_sort Junying Wei
title Precise Investigation of the Efficacy of Multicomponent Drugs Against Pneumonia Infected With Influenza Virus
title_short Precise Investigation of the Efficacy of Multicomponent Drugs Against Pneumonia Infected With Influenza Virus
title_full Precise Investigation of the Efficacy of Multicomponent Drugs Against Pneumonia Infected With Influenza Virus
title_fullStr Precise Investigation of the Efficacy of Multicomponent Drugs Against Pneumonia Infected With Influenza Virus
title_full_unstemmed Precise Investigation of the Efficacy of Multicomponent Drugs Against Pneumonia Infected With Influenza Virus
title_sort precise investigation of the efficacy of multicomponent drugs against pneumonia infected with influenza virus
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/b6d85b1016c9443280deb3843640f9d8
work_keys_str_mv AT junyingwei preciseinvestigationoftheefficacyofmulticomponentdrugsagainstpneumoniainfectedwithinfluenzavirus
AT jianhuisun preciseinvestigationoftheefficacyofmulticomponentdrugsagainstpneumoniainfectedwithinfluenzavirus
AT jiaweizeng preciseinvestigationoftheefficacyofmulticomponentdrugsagainstpneumoniainfectedwithinfluenzavirus
AT enhuiji preciseinvestigationoftheefficacyofmulticomponentdrugsagainstpneumoniainfectedwithinfluenzavirus
AT jingxu preciseinvestigationoftheefficacyofmulticomponentdrugsagainstpneumoniainfectedwithinfluenzavirus
AT chunyutang preciseinvestigationoftheefficacyofmulticomponentdrugsagainstpneumoniainfectedwithinfluenzavirus
AT hairuhuo preciseinvestigationoftheefficacyofmulticomponentdrugsagainstpneumoniainfectedwithinfluenzavirus
AT yizhang preciseinvestigationoftheefficacyofmulticomponentdrugsagainstpneumoniainfectedwithinfluenzavirus
AT hongmeili preciseinvestigationoftheefficacyofmulticomponentdrugsagainstpneumoniainfectedwithinfluenzavirus
AT hongjunyang preciseinvestigationoftheefficacyofmulticomponentdrugsagainstpneumoniainfectedwithinfluenzavirus
_version_ 1718424934640779264